[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Leflunomide Market, Global Outlook and Forecast 2022-2028

August 2022 | 78 pages | ID: LFEC41652658EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Leflunomide in global, including the following market information:

Global Leflunomide Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Leflunomide Market Sales, 2017-2022, 2023-2028, (Tons)

Global top five Leflunomide companies in 2021 (%)

The global Leflunomide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

99% Purity Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Leflunomide include Sanofi, DM Pharma and Changzhou Yabang Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Leflunomide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Leflunomide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Leflunomide Market Segment Percentages, by Type, 2021 (%)
  • 99% Purity
  • 99.5% Purity
Global Leflunomide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Leflunomide Market Segment Percentages, by Application, 2021 (%)
  • Rheumatoid Arthritis
  • Other
Global Leflunomide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)

Global Leflunomide Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Leflunomide revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Leflunomide revenues share in global market, 2021 (%)

Key companies Leflunomide sales in global market, 2017-2022 (Estimated), (Tons)

Key companies Leflunomide sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Sanofi
  • DM Pharma
  • Changzhou Yabang Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Leflunomide Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Leflunomide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LEFLUNOMIDE OVERALL MARKET SIZE

2.1 Global Leflunomide Market Size: 2021 VS 2028
2.2 Global Leflunomide Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Leflunomide Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Leflunomide Players in Global Market
3.2 Top Global Leflunomide Companies Ranked by Revenue
3.3 Global Leflunomide Revenue by Companies
3.4 Global Leflunomide Sales by Companies
3.5 Global Leflunomide Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Leflunomide Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Leflunomide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Leflunomide Players in Global Market
  3.8.1 List of Global Tier 1 Leflunomide Companies
  3.8.2 List of Global Tier 2 and Tier 3 Leflunomide Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Leflunomide Market Size Markets, 2021 & 2028
  4.1.2 99% Purity
  4.1.3 99.5% Purity
4.2 By Type - Global Leflunomide Revenue & Forecasts
  4.2.1 By Type - Global Leflunomide Revenue, 2017-2022
  4.2.2 By Type - Global Leflunomide Revenue, 2023-2028
  4.2.3 By Type - Global Leflunomide Revenue Market Share, 2017-2028
4.3 By Type - Global Leflunomide Sales & Forecasts
  4.3.1 By Type - Global Leflunomide Sales, 2017-2022
  4.3.2 By Type - Global Leflunomide Sales, 2023-2028
  4.3.3 By Type - Global Leflunomide Sales Market Share, 2017-2028
4.4 By Type - Global Leflunomide Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Leflunomide Market Size, 2021 & 2028
  5.1.2 Rheumatoid Arthritis
  5.1.3 Other
5.2 By Application - Global Leflunomide Revenue & Forecasts
  5.2.1 By Application - Global Leflunomide Revenue, 2017-2022
  5.2.2 By Application - Global Leflunomide Revenue, 2023-2028
  5.2.3 By Application - Global Leflunomide Revenue Market Share, 2017-2028
5.3 By Application - Global Leflunomide Sales & Forecasts
  5.3.1 By Application - Global Leflunomide Sales, 2017-2022
  5.3.2 By Application - Global Leflunomide Sales, 2023-2028
  5.3.3 By Application - Global Leflunomide Sales Market Share, 2017-2028
5.4 By Application - Global Leflunomide Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Leflunomide Market Size, 2021 & 2028
6.2 By Region - Global Leflunomide Revenue & Forecasts
  6.2.1 By Region - Global Leflunomide Revenue, 2017-2022
  6.2.2 By Region - Global Leflunomide Revenue, 2023-2028
  6.2.3 By Region - Global Leflunomide Revenue Market Share, 2017-2028
6.3 By Region - Global Leflunomide Sales & Forecasts
  6.3.1 By Region - Global Leflunomide Sales, 2017-2022
  6.3.2 By Region - Global Leflunomide Sales, 2023-2028
  6.3.3 By Region - Global Leflunomide Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Leflunomide Revenue, 2017-2028
  6.4.2 By Country - North America Leflunomide Sales, 2017-2028
  6.4.3 US Leflunomide Market Size, 2017-2028
  6.4.4 Canada Leflunomide Market Size, 2017-2028
  6.4.5 Mexico Leflunomide Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Leflunomide Revenue, 2017-2028
  6.5.2 By Country - Europe Leflunomide Sales, 2017-2028
  6.5.3 Germany Leflunomide Market Size, 2017-2028
  6.5.4 France Leflunomide Market Size, 2017-2028
  6.5.5 U.K. Leflunomide Market Size, 2017-2028
  6.5.6 Italy Leflunomide Market Size, 2017-2028
  6.5.7 Russia Leflunomide Market Size, 2017-2028
  6.5.8 Nordic Countries Leflunomide Market Size, 2017-2028
  6.5.9 Benelux Leflunomide Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Leflunomide Revenue, 2017-2028
  6.6.2 By Region - Asia Leflunomide Sales, 2017-2028
  6.6.3 China Leflunomide Market Size, 2017-2028
  6.6.4 Japan Leflunomide Market Size, 2017-2028
  6.6.5 South Korea Leflunomide Market Size, 2017-2028
  6.6.6 Southeast Asia Leflunomide Market Size, 2017-2028
  6.6.7 India Leflunomide Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Leflunomide Revenue, 2017-2028
  6.7.2 By Country - South America Leflunomide Sales, 2017-2028
  6.7.3 Brazil Leflunomide Market Size, 2017-2028
  6.7.4 Argentina Leflunomide Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Leflunomide Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Leflunomide Sales, 2017-2028
  6.8.3 Turkey Leflunomide Market Size, 2017-2028
  6.8.4 Israel Leflunomide Market Size, 2017-2028
  6.8.5 Saudi Arabia Leflunomide Market Size, 2017-2028
  6.8.6 UAE Leflunomide Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Leflunomide Major Product Offerings
  7.1.4 Sanofi Leflunomide Sales and Revenue in Global (2017-2022)
  7.1.5 Sanofi Key News
7.2 DM Pharma
  7.2.1 DM Pharma Corporate Summary
  7.2.2 DM Pharma Business Overview
  7.2.3 DM Pharma Leflunomide Major Product Offerings
  7.2.4 DM Pharma Leflunomide Sales and Revenue in Global (2017-2022)
  7.2.5 DM Pharma Key News
7.3 Changzhou Yabang Pharmaceutical
  7.3.1 Changzhou Yabang Pharmaceutical Corporate Summary
  7.3.2 Changzhou Yabang Pharmaceutical Business Overview
  7.3.3 Changzhou Yabang Pharmaceutical Leflunomide Major Product Offerings
  7.3.4 Changzhou Yabang Pharmaceutical Leflunomide Sales and Revenue in Global (2017-2022)
  7.3.5 Changzhou Yabang Pharmaceutical Key News

8 GLOBAL LEFLUNOMIDE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Leflunomide Production Capacity, 2017-2028
8.2 Leflunomide Production Capacity of Key Manufacturers in Global Market
8.3 Global Leflunomide Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 LEFLUNOMIDE SUPPLY CHAIN ANALYSIS

10.1 Leflunomide Industry Value Chain
10.2 Leflunomide Upstream Market
10.3 Leflunomide Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Leflunomide Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Leflunomide in Global Market
Table 2. Top Leflunomide Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Leflunomide Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Leflunomide Revenue Share by Companies, 2017-2022
Table 5. Global Leflunomide Sales by Companies, (Tons), 2017-2022
Table 6. Global Leflunomide Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Leflunomide Price (2017-2022) & (US$/Ton)
Table 8. Global Manufacturers Leflunomide Product Type
Table 9. List of Global Tier 1 Leflunomide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Leflunomide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Leflunomide Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Leflunomide Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Leflunomide Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Leflunomide Sales (Tons), 2017-2022
Table 15. By Type - Global Leflunomide Sales (Tons), 2023-2028
Table 16. By Application – Global Leflunomide Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Leflunomide Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Leflunomide Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Leflunomide Sales (Tons), 2017-2022
Table 20. By Application - Global Leflunomide Sales (Tons), 2023-2028
Table 21. By Region – Global Leflunomide Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Leflunomide Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Leflunomide Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Leflunomide Sales (Tons), 2017-2022
Table 25. By Region - Global Leflunomide Sales (Tons), 2023-2028
Table 26. By Country - North America Leflunomide Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Leflunomide Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Leflunomide Sales, (Tons), 2017-2022
Table 29. By Country - North America Leflunomide Sales, (Tons), 2023-2028
Table 30. By Country - Europe Leflunomide Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Leflunomide Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Leflunomide Sales, (Tons), 2017-2022
Table 33. By Country - Europe Leflunomide Sales, (Tons), 2023-2028
Table 34. By Region - Asia Leflunomide Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Leflunomide Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Leflunomide Sales, (Tons), 2017-2022
Table 37. By Region - Asia Leflunomide Sales, (Tons), 2023-2028
Table 38. By Country - South America Leflunomide Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Leflunomide Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Leflunomide Sales, (Tons), 2017-2022
Table 41. By Country - South America Leflunomide Sales, (Tons), 2023-2028
Table 42. By Country - Middle East & Africa Leflunomide Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Leflunomide Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Leflunomide Sales, (Tons), 2017-2022
Table 45. By Country - Middle East & Africa Leflunomide Sales, (Tons), 2023-2028
Table 46. Sanofi Corporate Summary
Table 47. Sanofi Leflunomide Product Offerings
Table 48. Sanofi Leflunomide Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 49. DM Pharma Corporate Summary
Table 50. DM Pharma Leflunomide Product Offerings
Table 51. DM Pharma Leflunomide Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 52. Changzhou Yabang Pharmaceutical Corporate Summary
Table 53. Changzhou Yabang Pharmaceutical Leflunomide Product Offerings
Table 54. Changzhou Yabang Pharmaceutical Leflunomide Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 55. Leflunomide Production Capacity (Tons) of Key Manufacturers in Global Market, 2020-2022 (Tons)
Table 56. Global Leflunomide Capacity Market Share of Key Manufacturers, 2020-2022
Table 57. Global Leflunomide Production by Region, 2017-2022 (Tons)
Table 58. Global Leflunomide Production by Region, 2023-2028 (Tons)
Table 59. Leflunomide Market Opportunities & Trends in Global Market
Table 60. Leflunomide Market Drivers in Global Market
Table 61. Leflunomide Market Restraints in Global Market
Table 62. Leflunomide Raw Materials
Table 63. Leflunomide Raw Materials Suppliers in Global Market
Table 64. Typical Leflunomide Downstream
Table 65. Leflunomide Downstream Clients in Global Market
Table 66. Leflunomide Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Leflunomide Segment by Type
Figure 2. Leflunomide Segment by Application
Figure 3. Global Leflunomide Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Leflunomide Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Leflunomide Revenue, 2017-2028 (US$, Mn)
Figure 7. Leflunomide Sales in Global Market: 2017-2028 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Leflunomide Revenue in 2021
Figure 9. By Type - Global Leflunomide Sales Market Share, 2017-2028
Figure 10. By Type - Global Leflunomide Revenue Market Share, 2017-2028
Figure 11. By Type - Global Leflunomide Price (US$/Ton), 2017-2028
Figure 12. By Application - Global Leflunomide Sales Market Share, 2017-2028
Figure 13. By Application - Global Leflunomide Revenue Market Share, 2017-2028
Figure 14. By Application - Global Leflunomide Price (US$/Ton), 2017-2028
Figure 15. By Region - Global Leflunomide Sales Market Share, 2017-2028
Figure 16. By Region - Global Leflunomide Revenue Market Share, 2017-2028
Figure 17. By Country - North America Leflunomide Revenue Market Share, 2017-2028
Figure 18. By Country - North America Leflunomide Sales Market Share, 2017-2028
Figure 19. US Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Leflunomide Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Leflunomide Sales Market Share, 2017-2028
Figure 24. Germany Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 25. France Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Leflunomide Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Leflunomide Sales Market Share, 2017-2028
Figure 33. China Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 37. India Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Leflunomide Revenue Market Share, 2017-2028
Figure 39. By Country - South America Leflunomide Sales Market Share, 2017-2028
Figure 40. Brazil Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Leflunomide Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Leflunomide Sales Market Share, 2017-2028
Figure 44. Turkey Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Leflunomide Revenue, (US$, Mn), 2017-2028
Figure 48. Global Leflunomide Production Capacity (Tons), 2017-2028
Figure 49. The Percentage of Production Leflunomide by Region, 2021 VS 2028
Figure 50. Leflunomide Industry Value Chain
Figure 51. Marketing Channels


More Publications